Related Experiment Video
Updated: Feb 6, 2026

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 7, 2010
Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARγ Activation.
Abdel G Elkahloun1, Yara Rodriguez2, Seham Alaiyed2
1Microarray Core, Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, National Institutes of Health, 50 South Dr, MSC 4435, Bethesda, MD, 20892-4435, USA.
Telmisartan demonstrates novel neuroprotective effects in microglia by downregulating inflammatory genes, independent of its known mechanisms. This suggests potential new therapeutic avenues for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Pharmacology
- Immunology
Background:
- Telmisartan, an Angiotensin II Receptor Blocker (ARB), is known to reduce inflammation via AT1 receptor blockade and PPARγ activation.
- Microglia play a crucial role in neuroinflammation, and their responses can be mimicked in cell lines like BV2.
- Understanding Telmisartan's effects beyond its known pathways is vital for exploring new therapeutic applications.
Purpose of the Study:
- To investigate the novel neuroprotective mechanisms of Telmisartan in a mouse microglia-like BV2 cell line.
- To explore Telmisartan's effects on gene expression related to inflammation, apoptosis, and neurodegeneration, independent of AT1 receptor and PPARγ pathways.
- To evaluate the neuroprotective potential of PPARγ antagonists and their interaction with Telmisartan.
Main Methods:
- Utilized a mouse microglia-like BV2 cell line, lacking AT1 receptor gene expression and PPARγ activation.
- Performed global gene expression profiling and pathway analysis to assess changes induced by Telmisartan and other agents.
- Employed Gene Set Enrichment Analysis (GSEA) to correlate gene expression changes with specific biological processes and disorders.
Main Results:
- Telmisartan reduced pro-injury gene expression and enhanced anti-inflammatory genes in BV2 cells, independent of AT1 receptor or PPARγ activation.
- Telmisartan normalized numerous LPS-upregulated genes linked to inflammation, apoptosis, and neurodegeneration.
- PPARγ antagonists (GW9662, T0070907) exhibited neuroprotective effects and potentiated Telmisartan's actions, notably through TLR2 signaling pathway downregulation.
Conclusions:
- Telmisartan possesses novel neuroprotective effects in microglia, involving the downregulation of the TLR2 signaling pathway.
- These findings suggest Telmisartan's potential therapeutic relevance for neurodegenerative diseases, extending beyond its established mechanisms.
- PPARγ antagonists may offer synergistic neuroprotection with Telmisartan by modulating inflammatory pathways.
Related Concept Videos
Neuromuscular Junction And Blockade
Internal Receptors
Types of Receptors: Cell Surface Receptors
Receptor-mediated Endocytosis
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...

